Pediatrix Medical Group, Inc. (NYSE:MD) Given Average Recommendation of "Hold" by Brokerages
Pediatrix Medical Group, Inc. (NYSE:MD) Given Average Recommendation of "Hold" by Brokerages
Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) has been given a consensus recommendation of "Hold" by the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $24.67.
据MarketBeat Ratings报道，Pediatrix Medical Group，Inc.(纽约证券交易所代码：MD-GET评级)已被目前负责该股票的八位分析师一致建议持有。四位研究分析师对该股的评级为持有建议，一位分析师给出了买入建议。在过去一年发布该股报告的分析师中，平均一年目标价为24.67美元。
Several research firms have recently commented on MD. BMO Capital Markets reduced their price target on Pediatrix Medical Group from $25.00 to $23.00 and set a "market perform" rating for the company in a research report on Wednesday, August 10th. Credit Suisse Group decreased their price target on shares of Pediatrix Medical Group from $30.00 to $28.00 and set an "outperform" rating for the company in a research report on Thursday, August 11th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on shares of Pediatrix Medical Group from $24.00 to $16.00 in a research report on Tuesday, May 10th.
几家研究公司最近对MD发表了评论。BMO Capital Markets在8月10日(星期三)的一份研究报告中将Pediatrix Medical Group的目标价从25.00美元下调至23.00美元，并为该公司设定了“市场表现”评级。瑞士信贷集团在8月11日(星期四)的一份研究报告中将Pediatrix Medical Group的股票目标价从30.00美元下调至28.00美元，并为该公司设定了“跑赢大盘”的评级。最后，德意志银行Aktiengesellschaft在5月10日星期二的一份研究报告中将Pediatrix Medical Group的股票目标价从24.00美元下调至16.00美元。
Hedge Funds Weigh In On Pediatrix Medical Group
对冲基金入股Pediatrix Medical Group
Several hedge funds have recently modified their holdings of MD. Envestnet Asset Management Inc. increased its holdings in shares of Pediatrix Medical Group by 4.2% in the fourth quarter. Envestnet Asset Management Inc. now owns 68,203 shares of the company's stock valued at $1,856,000 after purchasing an additional 2,739 shares during the period. Victory Capital Management Inc. raised its position in Pediatrix Medical Group by 77.2% during the 1st quarter. Victory Capital Management Inc. now owns 58,243 shares of the company's stock worth $1,079,000 after buying an additional 25,378 shares during the last quarter. Granite Investment Partners LLC lifted its stake in Pediatrix Medical Group by 3.5% during the 4th quarter. Granite Investment Partners LLC now owns 612,371 shares of the company's stock valued at $16,663,000 after acquiring an additional 20,599 shares during the period. Palisade Capital Management LLC NJ boosted its holdings in shares of Pediatrix Medical Group by 0.9% in the 4th quarter. Palisade Capital Management LLC NJ now owns 648,925 shares of the company's stock valued at $17,657,000 after acquiring an additional 5,770 shares during the last quarter. Finally, SG Americas Securities LLC increased its stake in shares of Pediatrix Medical Group by 403.5% in the fourth quarter. SG Americas Securities LLC now owns 36,806 shares of the company's stock worth $1,001,000 after acquiring an additional 29,496 shares during the period. Institutional investors and hedge funds own 95.98% of the company's stock.
几家对冲基金最近调整了对MD的持股。Envestnet Asset Management Inc.在第四季度增持了4.2%的Pediatrix Medical Group股票。Envestnet Asset Management Inc.在此期间又购买了2,739股，目前持有68,203股该公司股票，价值1,856,000美元。第一季度，胜利资本管理公司将其在Pediatrix Medical Group的持仓提高了77.2%。胜利资本管理公司现在持有58,243股该公司股票，价值1,079,000美元，该公司在上个季度又购买了25,378股。Granite Investment Partners LLC在第四季度增持了Pediatrix Medical Group 3.5%的股份。在此期间增持了20,599股后，Granite Investment Partners LLC现在拥有612,371股该公司的股票，价值16,663,000美元。新泽西州Palisade Capital Management LLC在第四季度增持了Pediatrix Medical Group的股票0.9%。新泽西州Palisade Capital Management LLC现在拥有该公司648,925股股票，价值17,657,000美元，上个季度又收购了5,770股。最后，SG America Securities LLC在第四季度增持了403.5%的Pediatrix Medical Group股票。在此期间，SG America Securities LLC额外收购了29,496股，目前拥有36,806股该公司股票，价值1,001,000美元。机构投资者和对冲基金持有该公司95.98%的股票。
Pediatrix Medical Group Stock Performance
儿科医疗集团股票表现
Pediatrix Medical Group (NYSE:MD – Get Rating) last announced its quarterly earnings results on Thursday, August 4th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.04. The firm had revenue of $486.00 million during the quarter, compared to analysts' expectations of $491.54 million. Pediatrix Medical Group had a net margin of 4.30% and a return on equity of 16.15%. The company's revenue was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.36 EPS. As a group, equities research analysts forecast that Pediatrix Medical Group will post 1.71 EPS for the current fiscal year.
Pediatrix医疗集团(纽约证券交易所代码：MD-GET评级)最近一次公布季度收益结果是在8月4日星期四。该公司公布本季度每股收益为0.47美元，比普遍预期的0.43美元高出0.04美元。该公司本季度营收为4.86亿美元，高于分析师预期的4.9154亿美元。儿科医疗集团的净利润率为4.30%，股本回报率为16.15%。与去年同期相比，该公司的收入增长了2.7%。去年同期，该公司每股收益为0.36美元。作为一个整体，股票研究分析师预测，Pediatrix Medical Group本财年的每股收益将达到1.71股。
About Pediatrix Medical Group
关于儿科医疗集团
(Get Rating)
(获取评级)
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
儿科医疗集团及其子公司在美国和波多黎各提供新生儿、母婴、儿科心脏病和其他儿科专科护理服务。它通过新生儿内科专科医生、新生儿护士执业医生和其他儿科临床医生，为医院特定单元内早产或有并发症的婴儿提供新生儿护理服务。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Pediatrix Medical Group (MD)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
- 免费获取StockNews.com关于儿科医疗集团(MD)的研究报告
- 随着管理层重组，股市能否迅速反弹？
- MarketBeat：回顾中的一周8/29-9/2
- 霍梅尔在这些水平上看起来很便宜
- 露露柠檬将飙升至9月
- 耐克股票会被超卖，但仍被高估吗？
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
接受《儿科医疗集团日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Pediatrix Medical Group和相关公司的最新新闻和分析师评级的每日简要摘要。